Filter
346
Featured
Language
Document type
121
116
62
22
9
5
3
2
2
2
1
1
Countries
8
7
7
6
5
5
4
3
3
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
64
55
50
38
31
11
8
7
6
5
5
5
5
4
4
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
53
29
7
3
2
1
1
Technical Report AIDS Medicines and diagnostics service July 2015

HIV/AIDS Diagnostics Technology Landscape - 5th edition

Unitaid; World Health Organization (2015) C_WHO
October 2015
Technical Report AIDS Medicines and diagnostics service July 2015
Supplement Article WHO Guidelines for HIV PEP • CID 2015:60 (Suppl 3), S161 - S164
This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing thirty key questions about PrEP and how it might be implemented in the UK.

Oral pre-exposure prophylaxis - Putting a new choice in context

UNAIDS (Joint United Nations Programme on HIVAIDS); World Health Organization (WHO); Global Advocacy for HIV Prevention (AVAC) UNAIDS (Joint United Nations Programme on HIVAIDS); World Health Organization (WHO); Global Advocacy for HIV Prevention (AVAC) (2015) C2
Reference
Supplement Article Antiretrovirals to Prevent HIV Infection • CID 2015:60 (Suppl 3) • S159 - S160
Pre-exposure prophylaxis (PrEP) Policy Brief November 2015
Technical report February 2015
v4, issued 11 June 2015
Public Report PQMC 0003-003-00 WHO PQMC PR June/2015, version 2.0
Guidelines HIV testing services July 2015
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection
Contraceptive Dynamics Following HIV Testing
Compendium of Case Studies

HIV Continuum of Care Monitoring Framework

Pan American Health Organization; World Health Organization (Americas) Pan American Health Organization; World Health Organization (Americas) (2014) C_WHO
2014 Addendum to meeting report: Regional consultation on HIV epidemiologic information in Latin America and the Caribbean

Expert Advisory Group on AIDS

GOV.UK developer docs; EAGA GOV.UK developer docs; EAGA (2014) C2
Providing expert scientific advice on HIV EAGA Secretariat
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re ... more
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approach : December 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs ... more